General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Cash Flows from Operating Activities        
Net loss $ (3,393,975) $ (3,931,889) $ (5,678,418) $ (7,912,512)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation: 401(k) stock 28,844 34,571 63,414 81,399
Stock-based compensation: Options and warrants 226,502 388,331 716,249 623,907
Gain on foreign currency translation 32,334 187,660
Net realized and unrealized investment losses 1,773 16,451 18,561 16,287
Depreciation and amortization 112,159 89,418 171,749 193,065
Loss on disposal of asset 410    
ROU asset amortization 107,411    
Amortization of debt discount 14,736 234,550 259,709 12,217
Provision for uncollectible assets (27,874) (163,613) 76,215
Write-down of inventory     61,000
Gain on sale of investment in subsidiary     199,200
Decrease (increase) in assets:        
Accounts receivable (378,729) 525,421 281,677 (246,917)
Inventory (179,889) (145,837) (191,973) (394,728)
Prepaid expenses and other current assets (1,480) (132,079) (255,240) (124,378)
Increase (decrease) in liabilities:        
Accounts payable and accrued expenses 182,128 179,010 724,014 (511,915)
Changes in operating lease liabilities (92,420)    
Deferred revenue (572,023) (185,147) 246,881
Other liabilities (14,678) 81,579 80,745 3,380
Total Adjustments (25,567) 671,518 1,332,485 (162,787)
Net Cash Used in Operating Activities (3,419,542) (3,260,371) (4,345,933) (8,075,299)
Cash Flows from Investing Activities        
Purchase of property and equipment (121,519) (326,799) (292,213) (930,368)
Proceeds from sale of investment in subsidiary     81,114
Net Cash Used in Investing Activities (121,519) (326,799) (292,213) (849,254)
Cash Flows from Financing Activities        
Proceeds from loans payable 580,386 580,386 519,157
Repayments of loans payable (80,235) (51,961) (199,910) (104,645)
Proceeds from convertible debt obligations 786,000 2,026,730 3,507,530 1,280,000
Repayments of debt obligations (95,500) (162,500)
Dividends paid in cash (127,913) (127,502) (60,515)
Proceeds from sale of Series B preferred stock     7,759,500
Proceeds from common stock offering, net of issuance costs 3,009,750 575,400 1,323,695 40,500
Net Cash Provided by Financing Activities 3,620,015 3,002,642 5,084,199 9,271,497
Effect of Exchange Rate Changes on Cash 230,722 373,359 (745,868) (119,831)
Net Increase (Decrease) in Cash 309,676 (211,169) (299,815) 227,113
Cash - Beginning of Period 58,488 358,303 358,303 131,190
Cash - End of Period 368,164 147,134 58,488 358,303
Supplemental Disclosures of Cash Flow Information:        
Interest paid 167,313 181,439 358,114 185,364
Income taxes paid
Non-Cash Investing and Financing Activity        
Accrued stock-based compensation converted to equity 63,415 81,399 81,399 73,868
Debt and interest converted to equity 52,660 809,875 809,875 1,267,324
Notes payable exchanged for noncontrolling interest 2,106,608    
Common stock returned to Company to satisfy receivable 32,285 32,285
Beneficial conversion feature 227,424 227,414
Dividends declared on Series B Convertible Redeemable Preferred Stock 474,719 474,719
Common stock issued to satisfy dividends payable $ 264,272 264,272
Common stock issued in satisfaction of deferred revenue     124,539
Land purchased in exchange for note payable     $ 517,390